Discontinued — last reported Q3 '23
Medtronic Derivative assets increased by 15.0% to $536.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 45.3%, from $980.00M to $536.00M. Over 4 years (FY 2021 to FY 2025), Derivative assets shows an upward trend with a 104.8% CAGR.
Fluctuations reflect changes in market conditions and the firm's overall derivative hedging or trading strategy.
This represents the fair value of derivative contracts that are in a gain position for the firm. These instruments are u...
Standard for large financial institutions with significant capital markets operations.
fin_derivative_assets| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $49.00M | $154.00M | $695.00M | $907.00M | $1.08B | $341.00M | $368.00M | $421.00M | $720.00M | $549.00M | $659.00M | $668.00M | $589.00M | $980.00M | $334.00M | $335.00M | $466.00M | $536.00M |
| QoQ Change | — | +214.3% | +351.3% | +30.5% | +19.3% | -68.5% | +7.9% | +14.4% | +71.0% | -23.8% | +20.0% | +1.4% | -11.8% | +66.4% | -65.9% | +0.3% | +39.1% | +15.0% |
| YoY Change | — | — | — | >999% | +602.6% | — | -47.1% | -53.6% | -33.5% | +61.0% | +79.1% | +58.7% | -18.2% | +78.5% | -49.3% | -49.9% | -20.9% | -45.3% |